Method to Assess Interactivity of Drugs with Nonparallel Concentration-Effect Relationships.

about

Method to Assess Interactivity of Drugs with Nonparallel Concentration-Effect Relationships.

Item

http://www.wikidata.org/entity/Q38866872

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Method to Assess Interactivity ...... ntration-Effect Relationships.

@en

type

Item

label

Method to Assess Interactivity ...... ntration-Effect Relationships.

@en

prefLabel

Method to Assess Interactivity ...... ntration-Effect Relationships.

@en

P1476

Method to Assess Interactivity ...... ntration-Effect Relationships.

@en

P2093

Jessie L-S Au

http://www.w3.org/2001/XMLSchema#string

Liang Zhao

http://www.w3.org/2001/XMLSchema#string

M Guillaume Wientjes

http://www.w3.org/2001/XMLSchema#string

P2860

What is synergy? The Saariselkä agreement revisited

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Drug combination studies and their synergy quantification using the Chou-Talalay method

Sequential combination of decitabine and idarubicin synergistically enhances anti-leukemia effect followed by demethylating Wnt pathway inhibitor promoters and downregulating Wnt pathway nuclear target.

Comparison of methods for evaluating drug-drug interaction.

CDK inhibitors in clinical development for the treatment of cancer.

HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL

Antimicrobial combinations: Bliss independence and Loewe additivity derived from mechanistic multi-hit models.

Metformin targets ovarian cancer stem cells in vitro and in vivo.

The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations.

P304

735-755

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1568009617666170330154054

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28359247

http://www.w3.org/2001/XMLSchema#string

P932

5623138

http://www.w3.org/2001/XMLSchema#string